I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Guo, Ren‐Feng
161
results:
Search for persons
X
Format
Online (161)
Mediatypes
Articles (Online) (102)
Bookchapter (Online) (2)
OpenAccess-fulltext (57)
Languages
english (151)
Sorted by: Relevance
Sorted by: Year
?
1
87. The safety and efficacy advantage of blocking C5a vs C5..:
Burnett, Bruce P
;
Lim, Endry H T
;
Vlaar, Alexander
...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023
Link:
https://doi.org/10.1093/..
?
2
Highly accurate and large-scale collision cross sections pr..:
Guo, Renfeng
;
Zhang, Youjia
;
Liao, Yuxuan
...
Communications Chemistry. 6 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
3
Pharmacokinetic analysis of vilobelimab, anaphylatoxin C5a ..:
Lim, Endry H. T.
;
Vlaar, Alexander P. J.
;
de Bruin, Sanne
...
Intensive Care Medicine Experimental. 11 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
4
The anti‐C5a antibody vilobelimab efficiently inhibits C5a ..:
Vlaar, Alexander P. J.
;
Lim, Endry H. T.
;
de Bruin, Sanne
...
Clinical and Translational Science. 15 (2022) 4 - p. 854-858 , 2022
Link:
https://doi.org/10.1111/..
?
5
LB1529. Randomized, Controlled Phase 3 Study of anti-C5a Vi..:
Mourvillier, Bruno
;
Vlaar, Alexander
;
Witzenrath, Martin
...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022
Link:
https://doi.org/10.1093/..
?
6
Efficacy and Safety of Vilobelimab (IFX-1), a Novel Monoclo..:
Bauer, Michael
;
Weyland, Andreas
;
Marx, Gernot
...
Critical Care Explorations. 3 (2021) 11 - p. e0577 , 2021
Link:
https://doi.org/10.1097/..
?
7
Elevated Plasma Complement Proteins in Palmoplantar Pustulo..:
Alavi, Afsaneh
;
Lowes, Michelle A.
;
Lu, Justin D.
...
Journal of Cutaneous Medicine and Surgery. 25 (2021) 4 - p. 449-450 , 2021
Link:
https://doi.org/10.1177/..
?
8
Spliceosome protein Eftud2 promotes colitis-associated tumo..:
Lv, Zhonglin
;
Wang, Zhihong
;
Luo, Longlong
...
Mucosal Immunology. 12 (2019) 5 - p. 1164-1173 , 2019
Link:
https://doi.org/10.1038/..
?
9
Treatment of Paraquat-Induced Lung Injury With an Anti-C5a ..:
Sun, Shihui
;
Jiang, Yuting
;
Wang, Renxi
...
Critical Care Medicine. 46 (2018) 5 - p. e419-e425 , 2018
Link:
https://doi.org/10.1097/..
?
10
Blockade of the C5a–C5aR axis alleviates lung damage inhDPP..:
Jiang, Yuting
;
Zhao, Guangyu
;
Song, Nianping
...
Emerging Microbes & Infections. 7 (2018) 1 - p. 1-12 , 2018
Link:
https://doi.org/10.1038/..
?
11
Controlling complement 5a (C5a) in disease setting requires..:
Guo, Renfeng
;
Habel, Maria
;
Ziereisen, Jana
...
Molecular Immunology. 102 (2018) - p. 158 , 2018
Link:
https://doi.org/10.1016/..
?
12
Controlling the anaphylatoxin C5a in diseases requires a sp..:
Riedemann, Niels C.
;
Habel, Maria
;
Ziereisen, Jana
...
Clinical Immunology. 180 (2017) - p. 25-32 , 2017
Link:
https://doi.org/10.1016/..
?
13
An epithelial-to-mesenchymal transition-inducing potential ..:
Chen, Yaqiong
;
Zhao, Zhi
;
Chen, Yu
...
Scientific Reports. 7 (2017) 1 - p. , 2017
Link:
https://doi.org/10.1038/..
?
14
Treatment With Anti-C5a Antibody Improves the Outcome of H7..:
Sun, Shihui
;
Zhao, Guangyu
;
Liu, Chenfeng
...
Clinical Infectious Diseases. 60 (2015) 4 - p. 586-595 , 2015
Link:
https://www.jstor.org/st..
?
15
The role of C5a in acute lung injury induced by highly path..:
Wang, Renxi
;
Xiao, He
;
Guo, Renfeng
..
Emerging Microbes & Infections. 4 (2015) 1 - p. 1-7 , 2015
Link:
https://doi.org/10.1038/..
1-15